In addition, the CAR T cells also acts as a medium to achieve local delivery of anti-CD47 antibodies, reduce the impact on normal cells, and block the anti-phagocytosis effect of tumor cells, thus ameliorating the immunosuppressive TME, diminishing tumor immune evasion. This evidence concerns the gene CD47 and neoplasm.